The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Open accessAbstract
CRISPR-Cas9–based genetic screens are a powerful new tool in biology. By simply altering the sequence of the single-guide RNA (sgRNA), one can reprogram Cas9 to target different sites in the genome with relative ease, but the on-target activity and off-target effects of individual sgRNAs can vary widely. Here, we use recently devised sgRNA design rules to create human and mouse genome-wide libraries, perform positive and negative selection screens and observe that the use of these rules produced improved results. Additionally, we profile the off-target activity of thousands of sgRNAs and develop a metric to predict off-target sites. We incorporate these findings from large-scale, empirical data to improve our computational design rules and create optimized sgRNA libraries that maximize on-target activity and minimize off-target effects to enable more effective and efficient genetic screens and genome engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, it can identify genes related to drug resistance in cancer cells and facilitate research on overcoming this resistance [8].”
From A Review of Research on CRISPR/Cas9 Gene Editing Technology in Disease Treatment (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The CFD algorithm is derived from a CRISPR/Cas9 genetic screen experiment that assessed the off-target effects of thousands of sgRNAs (Doench et al., 2016).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Doench et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Primarily, the sequence of sgRNAs is a crucial factor affecting on-target and off target efficiency.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Doench et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Different sgRNAs targeting the same gene locus can have distinct outcomes”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Doench et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“We used the STARS algorithm (Doench et al., 2016) to derive 38 hits, 18 of which were shared across at least two cell lines”
From Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma (2020) · cites this paper as Doench et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“In addition, although our sgRNA pool was designed in silico to minimize the probability of SpCas9 off-target activity52, the GUIDE-seq assay for sgRNA+119 revealed 11 off-target sites throughout the genome (Supplementary Figs. 11h and 4d).”
From Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing (2019) · cites this paper as [52]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although TREM2 has been shown to bind to Aβ and facilitate its uptake80,81, the surface expression changes of other receptors involved in Aβ recognition and uptake might have counteracted the effects of increased TREM2 signaling upon INPP5D haploinsufficiency83,84.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, Aβ can bind to lipoproteins such as clusterin (ApoJ) and ApoE in the brain82–84, which facilitates its clearance by microglia via TREM281.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Molecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111
Biopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Steiger, J.H. Tests for comparing elements of a correlation matrix. Psychol. Bull. 87, 245–251 (1980). · DOI · Paper page
Cited by
Sorted by citations
Items 901–1,000 of 1,030
Design of Guide RNA for CRISPR/Cas Plant Genome Editing
Геращенков, Г. А., Rozhnova, N. A., Кулуев, Б. Р., Kiryanova, O. Y., Гумерова, Г. Р., Knyazev, A. V., Vershinina, Z. R., Mikhailova, E. V., Chemeris, D. A., Matniyazov, R. T., et al. (2020) · Molecular Biology · doi:10.1134/s0026893320010069 · Cited by 49
Butz, S., Schmolka, N., Karemaker, I. D., Villaseñor, R., Schwarz, I., Domcke, S., Uijttewaal, E. C. H., Jude, J., Lienert, F., Krebs, A. R., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01210-z · Cited by 44
Derakhshankhah, H., Sajadimajd, S., Jafari, S., Izadi, Z., Sarvari, S., Sharifi, M., Falahati, M., Moakedi, F., Muganda, W. C. A., Müller, M., et al. (2020) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2020.102149 · Cited by 48
CRISPR-Based Genetic Manipulation of Candida Species: Historical Perspectives and Current Approaches
Uthayakumar, D., Sharma, J., Wensing, L. F., & Shapiro, R. S. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.606281 · Cited by 53
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts
Ellegast, J. M., Alexe, G., Hamze, A., Lin, S., Uckelmann, H. J., Rauch, P. J., Pimkin, M., Ross, L. S., Dharia, N. V., Robichaud, A. L., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0956 · Cited by 49
A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DR
Deseke, M., Rampoldi, F., Sandrock, I., Borst, E. M., Böning, H., Ssebyatika, G. L., Jürgens, C., Plückebaum, N., Beck, M., Hassan, A., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212525 · Cited by 48
Specificity of oligonucleotide gene therapy (OGT) agents
Nedorezova, D. D., Dubovichenko, M. V., Belyaeva, E. P., Grigorieva, E. D., Peresadina, A. V., & Kolpashchikov, D. M. (2022) · Theranostics · doi:10.7150/thno.77830 · Cited by 50
Gunn, K., Myllykoski, M., Cao, J. Z., Ahmed, M., Huang, B., Rouaisnel, B., Diplas, B. H., Levitt, M. M., Looper, R., Doench, J. G., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0825 · Cited by 57
Self-citationSchoonenberg, V. A. C., Cole, M. A., Yao, Q., Macias-Treviño, C., Sher, F., Schupp, P. G., Canver, M. C., Maeda, T., Pinello, L., & Bauer, D. E. (2018) · Genome biology · doi:10.1186/s13059-018-1563-5 · Cited by 49
Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells
Oh, S. A., Seki, A., & Rutz, S. (2018) · Current Protocols in Immunology · doi:10.1002/cpim.69 · Cited by 48
Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening
Sun, N., Petiwala, S. M., Wang, R., Lu, C., Hu, M., Ghosh, S., Hao, Y., Miller, C. P., & Chung, N. (2019) · BMC Genomics · doi:10.1186/s12864-019-5601-9 · Cited by 49
Editing the Central Nervous System Through CRISPR/Cas9 Systems
Cota-Coronado, A., Díaz-Martínez, N. F., Padilla‐Camberos, E., & Diaz-Martinez, N. E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00110 · Cited by 51
WheatCRISPR: a web-based guide RNA design tool for CRISPR/Cas9-mediated genome editing in wheat
Cram, D., Kulkarni, M. M., Buchwaldt, M., Rajagopalan, N., Bhowmik, P., Rozwadowski, K. L., Parkin, I. A. P., Sharpe, A., & Kagale, S. (2019) · BMC Plant Biology · doi:10.1186/s12870-019-2097-z · Cited by 49
Integrated analysis of H2A.Z isoforms function reveals a complex interplay in gene regulation
Lamaa, A., Humbert, J., Aguirrebengoa, M., Cheng, X., Nicolas, E., Côté, J., & Trouche, D. (2020) · eLife · doi:10.7554/elife.53375 · Cited by 51
Fontana, J. T., Sparkman-Yager, D., Zalatan, J. G., & Carothers, J. M. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.04.005 · Cited by 47
Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages
Navarro‐Guerrero, E., Tay, C., Whalley, J. P., Cowley, S. A., Davies, B., Knight, J. C., & Ebner, D. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-82137-z · Cited by 48
H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility
Giambartolomei, C., Seo, J.-H., Schwarz, T., Freund, M. K., Johnson, R., Spisák, S., Baca, S. C., Gusev, A., Mancuso, N., Paşaniuc, B., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.11.007 · Cited by 49
Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes
Vicencio, J., Sánchez-Bolaños, C., Moreno-Sánchez, I., Brena, D., Vejnar, C. E., Kukhtar, D., Ruiz-López, M., Cots-Ponjoan, M., Rubio, A., Melero, N. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30228-4 · Cited by 47
In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cells
Huang, B., Phelan, J. D., Preite, S., Gómez‐Rodríguez, J., Johansen, K. H., Shibata, H., Shaffer, A. L., Xu, Q., Jeffrey, B. M., Kirby, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28378-6 · Cited by 48
Israeli, M., Finkel, Y., Yahalom-Ronen, Y., Paran, N., Chitlaru, T., Israeli, O., Cohen-Gihon, I., Aftalion, M., Falach, R., Rotem, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29896-z · Cited by 46
Otto, J. E., Ursu, O., Wu, A. P., Winter, E. B., Cuoco, M. S., Ma, S., Qian, K., Michel, B. C., Buenrostro, J. D., Berger, B., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.03.013 · Cited by 50
Kendirli, A., del Val, C. D. L. R., Lämmle, K. F., Eglseer, K., Bauer, I., Kavaka, V., Winklmeier, S., Zhuo, L., Wichmann, C. W., Gerdes, L. A., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01432-2 · Cited by 57
Benchmarking deep learning methods for predicting CRISPR/Cas9 sgRNA on- and off-target activities
Zhang, G., Luo, Y., Dai, X., & Dai, Z. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad333 · Cited by 47
Implantation of engineered adipocytes suppresses tumor progression in cancer models
Nguyen, H. P., An, K., Ito, Y., Kharbikar, B. N., Sheng, R. R., Paredes, B., Murray, E., Pham, K., Brück, M., Zhou, X., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02551-2 · Cited by 49
Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3
Chen, K. Y., Kibayashi, T., Giguelay, A., Hata, M., Nakajima, S., Mikami, N., Takeshima, Y., Ichiyama, K., Omiya, R., Ludwig, L. S., et al. (2025) · Nature · doi:10.1038/s41586-025-08795-5 · Cited by 57
Baysoy, A., Tian, X., Renauer, P. A., Zhang, F., Bai, Z., Shi, H., Yang, M., Zhang, D., Liu, M., Li, H., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03127-y · Cited by 92
Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries
Ong, S. H., Li, Y., Koike-Yusa, H., & Yusa, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-07827-z · Cited by 47
Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
Ahmad, G., & Amiji, M. M. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.014 · Cited by 48
CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
Lone, B. A., Karna, S. K. L., Ahmad, F., Shahi, N., & Pokharel, Y. R. (2018) · Genetics Research International · doi:10.1155/2018/3797214 · Cited by 48
CRISPR/Cas9‐Mediated Knockout of MicroRNA‐744 Improves Antibody Titer of CHO Production Cell Lines
Raab, N., Mathias, S., Alt, K., Handrick, R., Fischer, S., Schmieder, V., Jadhav, V., Borth, N., & Otte, K. (2019) · Biotechnology Journal · doi:10.1002/biot.201800477 · Cited by 49
Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation
Šenigl, F., Maman, Y., Dinesh, R. K., Alinikula, J., Seth, R. B., Pecnová, Ľ., Omer, A. D., Rao, S. S. P., Weisz, D., Buerstedde, J.-M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.039 · Cited by 51
Resolving mechanisms of immune‐mediated disease in primary CD4 T cells
Bourges, C., Groff, A. F., Burren, O. S., Gerhardinger, C., Mattioli, K., Hutchinson, A., Hu, T. X., Anand, T., Epping, M. W., Wallace, C., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012112 · Cited by 45
Rafid, A. H. M., Toufikuzzaman, M., Rahman, M. S., & Rahman, M. S. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3531-9 · Cited by 48
Christidi, E., Huang, H., Shafaattalab, S., Maillet, A., Lin, E. C., Huang, K., Laksman, Z., Davis, M. K., Tibbits, G. F., & Brunham, L. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-65979-x · Cited by 45
A Three-Way Combinatorial CRISPR Screen for Analyzing Interactions among Druggable Targets
Zhou, P., Chan, B. K. C., Wan, Y. K., Yuen, C. T. L., Choi, G. C. G., Li, X., Tong, C. S. W., Zhong, S. S. W., Sun, J., Bao, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108020 · Cited by 46
Sladen, P. E., Perdigão, P. R. L., Salsbury, G., Novoselova, T. V., van der Spuy, J., Chapple, J. P., Yu‐Wai‐Man, P., & Cheetham, M. E. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.015 · Cited by 47
Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3 -ITD–Positive AML
Thomas, M. E. Z., Lu, X., Talebi, Z., Jeon, J. Y., Buelow, D. R., Gibson, A. A., Uddin, M. E., Brinton, L. T., Nguyen, J., Collins, M., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0071 · Cited by 49
Jiang, L., Ingelshed, K., Shen, Y., Boddul, S. V., Iyer, V. S., Kasza, Z., Sedimbi, S. K., Lane, D. P., & Wermeling, F. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1692 · Cited by 47
High-resolution characterization of gene function using single-cell CRISPR tiling screen
Yang, L., Chan, A. K. N., Miyashita, K., Delaney, C. D., Wang, X., Li, H., Pokharel, S. P., Li, S., Li, M., Xu, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24324-0 · Cited by 45
Raitskin, O., Schudoma, C., West, A., & Patron, N. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211598 · Cited by 50
Effective use of sequence information to predict CRISPR-Cas9 off-target
Zhang, Z.-R., & Jiang, Z. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.01.006 · Cited by 51
Wani, A. K., Akhtar, N., Singh, R., Prakash, A., Raza, S. H. A., Cavalu, S. D., Chopra, C., Madkour, M., Elolimy, A. A., & Hashem, N. M. (2022) · Veterinary Research Communications · doi:10.1007/s11259-022-09967-8 · Cited by 53
ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation
Sheriff, A., Guri, I., Żebrowska-Różańska, P., Llopis-Hernández, V., Brooks, I. R., Tekkela, S., Subramaniam, K. S., Gebrezgabher, R., Naso, G., Petrova, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24184-8 · Cited by 49
Gengatharan, J. M., Handzlik, M. K., Chih, Z. Y., Ruchhoeft, M. L., Secrest, P., Ashley, E. L., Green, C. R., Wallace, M., Gordts, P. L. S. M., & Metallo, C. M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.10.016 · Cited by 48
Exogenous RNA surveillance by proton-sensing TRIM25
Kim, M., Pyo, Y., Hyun, S., Jeong, M., Choi, Y., & Kim, V. N. (2025) · Science · doi:10.1126/science.ads4539 · Cited by 49
Schmieder, V., Bydlinski, N., Strasser, R., Baumann, M., Kildegaard, H. F., Jadhav, V., & Borth, N. (2017) · Biotechnology Journal · doi:10.1002/biot.201700211 · Cited by 46
Detecting and typing target DNA with a novel CRISPR-typing PCR (ctPCR) technique
Zhang, B., Xia, Q., Wang, Q., Xia, X., & Wang, J. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.09.012 · Cited by 46
Dandage, R., Després, P. C., Yachie, N., & Landry, C. R. (2019) · Genetics · doi:10.1534/genetics.119.302089 · Cited by 46
Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis
Shoda, T., Kaufman, K. M., Wen, T., Caldwell, J. M., Osswald, G. A., Pathre, P., Zimmermann, N., Collins, M. H., Rehn, K., Foote, H. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26939-9 · Cited by 47
From Genome Sequencing to CRISPR-Based Genome Editing for Climate-Resilient Forest Trees
Cao, H. X., Vu, G. T. H., & Gailing, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020966 · Cited by 56
Sintov, E., Nikolskiy, I., Barrera, V., Hyoje-Ryu Kenty, J., Atkin, A. S., Gerace, D., Ho Sui, S. J., Boulanger, K., & Melton, D. A. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.08.002 · Cited by 45
Identification of functional regulatory elements in the human genome using pooled CRISPR screens
Borys, S. M., & Younger, S. T. (2020) · BMC Genomics · doi:10.1186/s12864-020-6497-0 · Cited by 45
Gibson, A. R., Sateriale, A., Dumaine, J. E., Engiles, J. B., Pardy, R. D., Gullicksrud, J. A., O’Dea, K. M., Doench, J. G., Beiting, D. P., Hunter, C. A., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010003 · Cited by 45
Self-citationATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway
Huyghe, J., Priem, D., Hove, L. V., Gilbert, B., Fritsch, J. H., Uchiyama, Y., Hoste, E., Loo, G., & Bertrand, M. J. M. (2022) · Science · doi:10.1126/science.add6967 · Cited by 45
CRISPR/Cas-Based Diagnostics in Agricultural Applications
Tanny, T., Sallam, M., Soda, N., Nguyen, N., Alam, M. M., & Shiddiky, M. J. A. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00913 · Cited by 47
Genome Editing to Improve Abiotic Stress Responses in Plants
Osakabe, Y., & Osakabe, K. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.03.007 · Cited by 45
Potential impact of genome editing in world agriculture
Martínez-Fortún, J., Phillips, D. W., & Jones, H. D. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170010 · Cited by 46
CRISPR-Cas9-mediated generation of obese and diabetic mouse models
Roh, J.-I., Lee, J., Park, S.-U., Kang, Y.-S., Lee, J., Oh, A.-R., Choi, D. J., Cha, J.-Y., & Lee, H. (2018) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.17-0123 · Cited by 46
Visualizing Microglia with a Fluorescence Turn‐On Ugt1a7c Substrate
Kim, B., Fukuda, M., Lee, J. Y., Su, D., Sanu, S., Silvin, A., Khoo, A., Kwon, T., Liu, X., Chi, W., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903058 · Cited by 45
Rab35 controls cilium length, function and membrane composition
Kuhns, S., Seixas, C., Pestana, S., Tavares, B., Nogueira, R., Jacinto, R., Ramalho, J. S., Simpson, J. C., Andersen, J., Échard, A., et al. (2019) · EMBO Reports · doi:10.15252/embr.201847625 · Cited by 42
A benchmark of computational CRISPR-Cas9 guide design methods
Bradford, J., & Perrin, D. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007274 · Cited by 46
Technologies and Computational Analysis Strategies for CRISPR Applications
Clement, K., Hsu, J. Y., Canver, M. C., Joung, J. K., & Pinello, L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.012 · Cited by 45
Luanpitpong, S., Rodboon, N., Samart, P., Vinayanuwattikun, C., Klamkhlai, S., Pithi Chanvorachote, B., Rojanasakul, Y., & Issaragrisil, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0991-7 · Cited by 45
Illuminating Host-Mycobacterial Interactions with Genome-wide CRISPR Knockout and CRISPRi Screens
Lai, Y., Babunovic, G. H., Cui, L., Dedon, P. C., Doench, J. G., Fortune, S. M., & Lu, T. K. (2020) · Cell Systems · doi:10.1016/j.cels.2020.08.010 · Cited by 42
Self-citationNeural G0: a quiescent‐like state found in neuroepithelial‐derived cells and glioma
O’Connor, S. A., Feldman, H. M., Arora, S., Hoellerbauer, P., Toledo, C. M., Corrin, P. D., Carter, L. M., Kufeld, M., Bolouri, H., Basom, R., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209522 · Cited by 48
Yan, Y., Zhou, B. O., Chen, Q., Vasquez, A., Kamra, M., Chatterjee, A., Lee, Y., Yuan, X., Ellis, L., Vizio, D. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28340-6 · Cited by 46
Taylor, T., Sikorska, N., Shchuka, V. M., Chahar, S., Ji, C., Macpherson, N. N., Moorthy, S. D., de Kort, M. A. C., Mullany, S., Khader, N., et al. (2022) · Genes & Development · doi:10.1101/gad.349489.122 · Cited by 45
Spatially Resolved in vivo CRISPR Screen Sequencing via Perturb-DBiTPreprint
Baysoy, A., Tian, X., Zhang, F., Renauer, P. A., Bai, Z., Shi, H., Li, H., Tao, B., Yang, M., Enninful, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.18.624106 · Cited by 45
CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
Chemello, F., Olson, E. N., & Bassel‐Duby, R. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.053 · Cited by 47
Cui, Y., Miao, Y., Cao, L., Guo, L., Cui, Y., Yan, C., Zeng, Z., Xu, M., & Han, T. (2023) · Nature Communications · doi:10.1038/s41467-023-41101-3 · Cited by 44
Mandal, K., Wicaksono, G., Yu, C., Adams, J., Hoopmann, M. R., Temple, W. C., Izgutdina, A., Patiño-Escobar, B., Gorelik, M., Ihling, C. H., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00652-6 · Cited by 44
Genome-wide CRISPR guide RNA design and specificity analysis with GuideScan2
Schmidt, H., Zhang, M., Chakarov, D., Bansal, V., Mourelatos, H. A., Rivera, F. J. S., Lowe, S. W., Ventura, A., Leslie, C. S., & Pritykin, Y. (2025) · Genome biology · doi:10.1186/s13059-025-03488-8 · Cited by 48
Proximity-specific ribosome profiling reveals the logic of localized mitochondrial translation
Luo, J., Khandwala, S., Hu, J., Lee, S.-Y., Hickey, K. L., Levine, Z. G., Harper, J. W., Ting, A. Y., & Weissman, J. S. (2025) · Cell · doi:10.1016/j.cell.2025.08.002 · Cited by 44
CRISPR‐driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges
Wang, Z., Wang, Q., Zhang, J., Li, B., Li, Y., Chen, Z., Guo, D., & Feng, S. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70482 · Cited by 51
Tuning CRISPR-Cas9 Gene Drives in Saccharomyces cerevisiae
Roggenkamp, E., Giersch, R. M., Schrock, M. N., Turnquist, E., Halloran, M., & Finnigan, G. C. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300557 · Cited by 45
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Farboud, B., Jarvis, E., Roth, T. L., Shin, J. J., Corn, J. E., Marson, A., Meyer, B. J., Patel, N. H., & Hochstrasser, M. L. (2018) · Journal of Visualized Experiments · doi:10.3791/57350 · Cited by 52
Patil, A., Manzano, M., & Gottwein, E. (2018) · Blood · doi:10.1182/blood-2018-01-828418 · Cited by 45
The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
Darcis, G., Binda, C. S., Klaver, B., Herrera-Carrillo, E., Berkhout, B., & Das, A. T. (2019) · Viruses · doi:10.3390/v11030255 · Cited by 45
Pooled library screening with multiplexed Cpf1 library
Liu, J., Srinivasan, S., Li, C.-Y., Ho, I.-L., Rose, J. L., Shaheen, M., Wang, G., Yao, W., Deem, A. K., Bristow, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10963-x · Cited by 44
Elimination of infectious HIV DNA by CRISPR–Cas9
Das, A. T., Binda, C. S., & Berkhout, B. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.07.001 · Cited by 44
Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides
Sharma, P. A., Marada, V. V. V. R., Cai, Q., Kizerwetter, M., He, Y., Wolf, S. P., Schreiber, K., Clausen, H., Schreiber, H. W., & Kranz, D. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920662117 · Cited by 44
Inhibition of GCK-IV kinases dissociates cell death and axon regeneration in CNS neurons
Patel, A. K., Broyer, R. M., Lee, C. D., Lu, T., Louie, M., Torre, A. L., Al‐Ali, H., Vu, M. T., Mitchell, K. L., Wahlin, K. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004683117 · Cited by 45
A host receptor enables type 1 pilus-mediated pathogenesis of Escherichia coli pyelonephritis
McLellan, L. K., McAllaster, M. R., Kim, A. S., Tóthová, Ľ., Olson, P. D., Pinkner, J. S., Daugherty, A. L., Hreha, T. N., Janetka, J. W., Fremont, D. H., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009314 · Cited by 43
Self-citationSplit versions of Cleave and Rescue selfish genetic elements for measured self limiting gene drive
Oberhofer, G., Ivy, T., & Hay, B. A. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009385 · Cited by 44
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
Schmidt, O., Nehls, N., Prexler, C., von Heyking, K., Groll, T., Pardon, K., García, H. D., Hensel, T., Gürgen, D., Henssen, A. G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02125-z · Cited by 43
E3 ubiquitin ligase Wwp1 regulates ciliary dynamics of the Hedgehog receptor Smoothened
Lv, B., Stuck, M. W., Desai, P. B., Cabrera, O. A., & Pazour, G. J. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202010177 · Cited by 42
Uceda-Castro, R., van Asperen, J. V., Vennin, C., Sluijs, J. A., van Bodegraven, E. J., Margarido, A. S., Robe, P. A. J. T., van Rheenen, J., & Hol, E. M. (2022) · Scientific Reports · doi:10.1038/s41598-021-04127-5 · Cited by 45
FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
Cui, Z., Tian, R., Huang, Z., Jin, Z., Li, L., Liu, J., Huang, Z., Xie, H., Liu, D., Mo, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29089-8 · Cited by 46
Chronos: a CRISPR cell population dynamics modelPreprint
Dempster, J. M., Boyle, I., Vázquez, F., Root, D. E., Boehm, J. S., Hahn, W. C., Tsherniak, A., & McFarland, J. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.25.432728 · Cited by 44
Self-citationCRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer
Castells‐Roca, L., Tejero, E., Rodríguez‐Santiago, B., & Surrallés, J. (2021) · Cancers · doi:10.3390/cancers13071591 · Cited by 45
He, C., Liu, H., Chen, D., Xie, W., Wang, M., Li, Y., Gong, X., Yan, W., & Chen, L. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13675 · Cited by 43
Malireddi, R. K. S., Bynigeri, R. R., Mall, R., Nadendla, E. K., Connelly, J. P., Pruett‐Miller, S. M., & Kanneganti, T. (2023) · iScience · doi:10.1016/j.isci.2023.106938 · Cited by 46
GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies
Benbarche, S., Pineda, J. M. B., Galvis, L. D. B., Biswas, J., Liu, B., Wang, E., Zhang, Q., Hogg, S. J., Lyttle, K. A., Dahi, A., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.04.006 · Cited by 45
Comprehensive Protocols for CRISPR/Cas9‐based Gene Editing in Human Pluripotent Stem Cells
Santos, D. P., Kiskinis, E., Eggan, K. C., & Merkle, F. T. (2016) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.15 · Cited by 45
Benchmarking CRISPR on-target sgRNA design
Yan, J., Chuai, G., Zhou, C., Zhu, C., Yang, J., Zhang, C., Gu, F., Xu, H., Wei, J., & Liu, Q. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx001 · Cited by 42
An automated microfluidic gene-editing platform for deciphering cancer genes
Sinha, H., Quach, A. B. V., Vo, P. Q. N., & Shih, S. C. C. (2018) · Lab on a Chip · doi:10.1039/c8lc00470f · Cited by 44
Fortin, J., Tan, J., Gascoigne, K. E., Haverty, P. M., Forrest, W. F., Costa, M. R., & Martin, S. E. (2019) · Genome biology · doi:10.1186/s13059-019-1621-7 · Cited by 42
Leukemia-derived exosomes and cytokines pave the way for entry into the brain
Kinjyo, I., Евгеньевич, Б. Д., Grattan, R. M., Winter, S. S., & Wilson, B. S. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0218-054r · Cited by 43
A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast
Zhang, X., He, J.-B., Wang, Y.-Z., & Du, L. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200164 · Cited by 43
Talbot, B. E., Vandorpe, D. H., Stotter, B. R., Alper, S. L., & Schlöndorff, J. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008299 · Cited by 43
Metadata
- Authors
- Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., Virgin, H. W., Listgarten, J., & Root, D. E.
- Affiliations
- Broad Institute (US)
- Washington University in St. Louis (US)
- Microsoft Research New England (United States) (US)
- Corresponding author
- Doench, John G
- Listgarten, Jennifer
- Root, David E
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2016-01-18
- Volume
- 34
- Issue
- 2
- Pages
- 184-191
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4744125
- OpenAlex
- W2252568502
- Semantic Scholar
- b9e5fa707e804d6008e5011b058244437c656a93
- Cited by
- 4,637
- References
- 54
- Citations by year
- 2026: 494 · 2025: 658 · 2024: 569 · 2023: 572 · 2022: 538 · 2021: 499 · 2020: 463 · 2019: 337 · 2018: 258 · 2017: 170 · 2016: 75
- FWCI
- 144.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (K12CA087723)
- National Institute of Allergy and Infectious Diseases (U19AI109725, T32AI007163)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- sgRNA design, CRISPR/Cas9, off-target effects, on-target activity, genetic screen, off-target prediction, genome editing, human genome, mouse genome
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Animals, Drug Resistance, Genetic Engineering, Humans, Gene Library, Genome, Genomics, Cell Line, Tumor, Mice, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
